These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 34870621
1. Evaluation of Clinical Efficacy and Safety of Prolonged Treatment of Vernal and Atopic Keratoconjunctivitis Using Topical Tacrolimus. Hirota A, Shoji J, Inada N, Shiraki Y, Yamagami S. Cornea; 2022 Jan 01; 41(1):23-30. PubMed ID: 34870621 [Abstract] [Full Text] [Related]
2. Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis. Shoji J, Ohashi Y, Fukushima A, Miyazaki D, Uchio E, Takamura E, Fujishima H, Namba K, Kumagai N, Ebihara N, Okamoto S. Curr Eye Res; 2019 Jul 01; 44(7):796-805. PubMed ID: 30947551 [Abstract] [Full Text] [Related]
3. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. Ebihara N, Ohashi Y, Uchio E, Okamoto S, Kumagai N, Shoji J, Takamura E, Nakagawa Y, Nanba K, Fukushima A, Fujishima H. J Ocul Pharmacol Ther; 2009 Aug 01; 25(4):365-72. PubMed ID: 19441889 [Abstract] [Full Text] [Related]
4. The efficacy of 0.1% tacrolimus ophthalmic suspension in the treatment of severe atopic keratoconjunctivitis. Yazu H, Shimizu E, Aketa N, Dogru M, Okada N, Fukagawa K, Fujishima H. Ann Allergy Asthma Immunol; 2019 Apr 01; 122(4):387-392.e1. PubMed ID: 30639466 [Abstract] [Full Text] [Related]
5. Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis. Kheirkhah A, Zavareh MK, Farzbod F, Mahbod M, Behrouz MJ. Eye (Lond); 2011 Jul 01; 25(7):872-80. PubMed ID: 21475312 [Abstract] [Full Text] [Related]
8. Long-Term Safety and Efficacy of Tacrolimus 0.1% in Severe Pediatric Vernal Keratoconjunctivitis. Caputo R, Marziali E, de Libero C, Di Grande L, Danti G, Virgili G, Villani E, Mori F, Bacci GM, Lucenteforte E, Pucci N. Cornea; 2021 Nov 01; 40(11):1395-1401. PubMed ID: 34029239 [Abstract] [Full Text] [Related]
11. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis. Liu FY, Liu HY, Chu HS, Chen WL, Hu FR, Wang IJ. Graefes Arch Clin Exp Ophthalmol; 2019 May 01; 257(5):967-974. PubMed ID: 30852635 [Abstract] [Full Text] [Related]
17. Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis. Vichyanond P, Kosrirukvongs P. Curr Allergy Asthma Rep; 2013 Jun 01; 13(3):308-14. PubMed ID: 23625179 [Abstract] [Full Text] [Related]
18. Role of ocular cytology in vernal keratoconjunctivitis. Bruschi G, Ghiglioni DG, Osnaghi S, Rosazza C, Pires Marafon D, Landi M, Marchisio PG. Immun Inflamm Dis; 2020 Mar 01; 8(1):3-7. PubMed ID: 31804769 [Abstract] [Full Text] [Related]
19. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children. Labcharoenwongs P, Jirapongsananuruk O, Visitsunthorn N, Kosrirukvongs P, Saengin P, Vichyanond P. Asian Pac J Allergy Immunol; 2012 Sep 01; 30(3):177-84. PubMed ID: 23156846 [Abstract] [Full Text] [Related]
20. Late-term topical tacrolimus for subepithelial infiltrates resistant to topical steroids and ciclosporin secondary to adenoviral keratoconjunctivitis. Arici C, Mergen B. Br J Ophthalmol; 2021 May 01; 105(5):614-618. PubMed ID: 32563992 [Abstract] [Full Text] [Related] Page: [Next] [New Search]